A round of venture capital funding involving the Global Health Investment Fund and Visionary Venture Fund has brought in an undisclosed amount for Iantech. The proceeds will be used to support research and development and commercial efforts for the company's cataract treatment device, miLOOP technology.
Funding boost secured by cataract treatment device maker
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.